Alkosign Ltd
Alkosign Ltd (ALKOSIGN) last reported results for the quarter ended Mar 2026, with sales of ₹11.08 crore and net profit of ₹-5.15 crore. The stock last traded at ₹60, a market capitalisation of ₹64.8 crore, on a P/E of 8.93. Over the past 52 weeks the stock has ranged between ₹50.1 and ₹84.8. Figures are as of 6 Oct 2026 and are not real time.
Alkosign Ltd share price and key metrics
- Current price
- ₹60
- Market cap
- ₹64.8 cr
- Stock P/E
- 8.93
- Book value
- ₹26.2
- ROE
- 23.7%
- ROCE
- 18.6%
- Dividend yield
- 0.00%
- 52w high / low
- 84.8/50.1
Metrics as of 6 Oct 2026. Not real time.
Track Alkosign Ltd
Cruxal reads every Alkosign Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Alkosign Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -9%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 161%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -8%
- 1 Year
- -15%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 12%
- Last Year
- 24%
Alkosign Ltd quarterly results
In the quarter ended Mar 2026, sales were ₹11.08 cr, down 25.9% from ₹14.95 cr a year earlier. Net profit swung to a loss of ₹5.15 cr.
| ₹ crore | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 21.25 | 14.43 | 27.9 | 14.95 | 26.34 | 11.08 |
| Expenses | 12.65 | 18.52 | 23.06 | 12.3 | 24.39 | 10.16 |
| Operating profit | 8.6 | -4.09 | 4.84 | 2.65 | 1.95 | 0.92 |
| OPM % | 40.47% | -28.34% | 17.35% | 17.73% | 7.40% | 8.30% |
| Other income | 0.04 | 0.24 | 0.15 | -0.19 | 0.16 | -4.47 |
| Interest | 0.45 | 1.22 | 0.51 | 0.23 | 0.6 | 0.29 |
| Depreciation | 1.2 | 1.25 | 1.17 | 0.92 | 1.11 | 1.01 |
| Profit before tax | 6.99 | -6.32 | 3.31 | 1.31 | 0.4 | -4.85 |
| Tax % | 17.02% | -20.73% | 0.00% | 64.89% | 0.00% | 6.19% |
| Net profit | 5.8 | -5.02 | 3.31 | 0.46 | 0.39 | -5.15 |
| EPS (₹) | 5.37 | -4.65 | 3.06 | 0.43 | 0.36 | -4.77 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Alkosign Ltd annual results
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 35.69 | 29.39 | 26.7 |
| Operating profit | 4.51 | 6.08 | 9.74 |
| OPM % | 12.64% | 20.69% | 36.48% |
| Net profit | 0.78 | 3.77 | -4.76 |
| EPS (₹) | 0.72 | 3.49 | -4.41 |
TTM is the trailing twelve months to the most recent quarter.
Alkosign Ltd balance sheet
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity capital | 7.20 | 7.20 | 10.79 |
| Reserves | 22.02 | 25.79 | 17.43 |
| Borrowings | 13.85 | 12.55 | 13.20 |
| Other liabilities | 6.76 | 5.51 | 3.55 |
| Total liabilities | 49.83 | 51.05 | 44.97 |
| Fixed assets | 16.93 | 16.31 | 13.94 |
| CWIP | 0.61 | 0.54 | 0.43 |
| Investments | 0.10 | 0.00 | 0.00 |
| Other assets | 32.19 | 34.20 | 30.60 |
| Total assets | 49.83 | 51.05 | 44.97 |
As reported by the company. Total assets equal total liabilities by construction.
Alkosign Ltd cash flow
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Cash from operations | -0.81 | 0.85 | 1.63 |
| Cash from investing | -1.57 | -1.74 | 0.34 |
| Cash from financing | 8.05 | -2.38 | 0.16 |
| Net cash flow | 5.68 | -3.27 | 2.13 |
| Free cash flow | -2.40 | -0.82 | 2.10 |
| CFO / operating profit | -20% | 28% | 20% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Alkosign Ltd operating ratios
| Per year | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| ROCE % | — | 9.07% | 18.56% |
| Debtor days | 57.58 | 148.29 | 175.53 |
| Inventory days | 278.07 | 401.06 | 225.12 |
| Days payable | 97.88 | 93.88 | 51.14 |
| Cash conversion cycle | 237.77 | 455.46 | 349.50 |
| Working capital days | 109.33 | 210.63 | 150.65 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Alkosign Ltd shareholding pattern
Promoters held 45.92% at Mar 2026, up from 40.32% at Mar 2024. FIIs 9.94% and DIIs 5.48%.
| % held | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 50.41% | 53.28% | 53.28% | 40.32% | 41.32% | 41.89% | 43.35% | 45.92% |
| FIIs | 0.00% | 0.00% | 0.22% | 9.73% | 9.73% | 9.94% | 9.94% | 9.94% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.35% | 5.48% |
| Public | 49.60% | 46.74% | 46.52% | 49.94% | 48.94% | 48.17% | 43.36% | 38.66% |
| No. of shareholders | 316 | 295 | 549 | 660 | 757 | 651 | 615 | 529 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Alkosign Ltd corporate filings
- Alkosign Limited conducts a comprehensive AGM voting process with all resolutions passing with requisite majorities, including key appointments and related-party transaction approvals.AGM/EGMlow impact
Cruxal's analysis: Alkosign Limited, a small-cap company with a market cap of approximately INR 67 crore…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
Cruxal's analysis: Please find attached the Closure of Trading Window
Read the full analysis - Shareholder Meeting / Postal Ballot-Outcome of AGMAGM/EGMmedium impact
- Alkosign Limited Announces 6th AGM and Reports Financial Performance for FY 2025-26AGM/EGMhigh impact
Cruxal's analysis: Alkosign Limited has scheduled its 6th Annual General Meeting for September 29, 2026, to…
Read the full analysis - Alkosign Ltd releases Annual Report for the financial year 2025-26Otherslow impact
Cruxal's analysis: Alkosign Ltd has filed its Annual Report for the financial year 2025-26. The report…
Read the full analysis - Alkosign Limited Announces Board Re-appointments and Schedules 6th Annual General MeetingOtherslow impact
Cruxal's analysis: Alkosign Limited has announced the re-appointment of its Managing Director, Whole-Time…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.